Subscribe to
Alerts
Posts

Category Archive for 'News'

Source: Science Blogs: Framing CancerAuthor: Matthew C. Nisbet
Click for a larger view
As we discuss in a current working paper, the “going broad” strategy of using entertainment media to reach wider audiences was first pioneered in the area of health.
For example, working in collaboration with experts, screenwriters for the series ER purposely inserted plot scenarios intended [...]

Read Full Post »

2007, Susan and Jim Ralston received the news every parent dreads: their 2-year-old son was diagnosed with spinal Ewing’s sarcoma, a rare and aggressive cancer. This heart-breaking report was followed by a discovery from relatives that offered some comfort and hope: a relatively new radiation treatment, proton beam therapy. The Ralstons began a quest for more information and learned proton therapy could help their son improve his odds of beating cancer.

Read Full Post »

The 57-year-old lawyer in New York had handily completed the New York Times’ Saturday crossword puzzle – the hardest of the week – for years. But one Saturday morning, suddenly he couldn’t retrieve the words to fill in the squares.

Read Full Post »

They Call This Insurance?

Unable to work when stricken by brain cancer? Social Security Disability is there to help cover some of your lost income and steer you onto Medicaid for health insurance. Or it’s supposed to. Except when it doesn’t.

Read Full Post »

Radiation Therapy Oncology Group to hold meeting in June 2009, with a reception for advocates and interested parties.

Read Full Post »

The Ohio State University Comprehensive Cancer Center th James Cancer Hospital and Solove Research Institute will host the second annual Brain Tumor Awareness and Survivor Day Celebration on Saturday (5/9) from 10:30 a.m. to 2:30 p.m. at The Fawcett Center, 2400 Olentangy River Road.

Read Full Post »

Bobby Murcer Mobile MRI Unit in Washington, D.C. for Brain Tumor Awareness Month Provides Free Brain Scans to Members of Congress, Staff and Government Agency Officials.

Read Full Post »

The Burzynski Research Institute (BRI) announced today positive safety and efficacy results in its Phase II clinical trial of Antineoplaston A10 and Antineoplaston AS2-1 therapy (ANP therapy) in children with optic pathway glioma (OPG). The results were presented to the FDA in the Request for End of Phase II Meeting Briefing Package (ANP in OPG), to be discussed at a meeting with the FDA on May 7, 2009. The FDA responded to the questions in the Briefing Package and issued additional comments before the meeting. The answers and comments were clear, and the meeting was cancelled since further discussion was not required. Based on preliminary responses and additional comments from the FDA, a protocol for a Phase III randomized trial with ANP in OPG will be prepared and submitted for FDA Special Protocol Assessment (SPA) to secure agreement on the design of a Phase III trial to serve as an efficacy claim in a New Drug Application (NDA).

Read Full Post »

Genentech, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted accelerated approval of Avastin® (bevacizumab) for people with glioblastoma with progressive disease following prior therapy.

Read Full Post »

The Brain Tumor Foundation has launched an unprecedented campaign: Road to Early Detection, the first-ever national campaign promoting early detection of brain tumors through the use of a Mobile MRI Unit.

Read Full Post »

« Newer Posts - Older Posts »